Royalty Pharma must make an offer for Elan or announce it will not proceed by May 10th, the Irish Takeover Panel said.
The decision was made following representations by Elan and correspondence with advisers to both companies, the panel said in a statement today.
The deadline pressures New York-based Royalty to make a formal offer, following an “indicative proposal” on February 25th to buy Elan for about $6.5 billion, or $11 per American depository receipt....
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team